Q-omics provides the consensus-scored TRAJ56 profile across patient tissues and cancer cell-line models. TRAJ56 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in TGCT. Additionally, TRAJ56 RNA expression shows 7,058 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight TGCT, and LSCC as cancer lineages where TRAJ56 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.